Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?

Polyglutamine (polyQ) diseases are a group of inherited neurodegenerative disorders caused by the expansion of the cytosine-adenine-guanine (CAG) repeat. This mutation encodes extended glutamine (Q) tract in the disease protein, resulting in the alteration of its conformation/physiological role and...

Full description

Saved in:
Bibliographic Details
Published in:Front Cell Neurosci
Main Authors: Barros, Inês, Marcelo, Adriana, Silva, Teresa P., Barata, João, Rufino-Ramos, David, Pereira de Almeida, Luís, Miranda, Catarina O.
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Cellular Neuroscience
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7573388/
https://ncbi.nlm.nih.gov/pubmed/33132851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2020.584277
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items